Lupin has received approval from the Food and Drug Administration for risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial and 50 mg per vial, single-dose vials.
Out of 47 children who were screened, 40 patients were randomized into one of two groups. The reasons for the drop of patients in the two groups are displayed in Figure 1. The number of boys in the ...
A Nigerian pharmacist and researcher, Oyinlade Kehinde, has made a groundbreaking discovery about why the same drugs affect individual patients differently, with a mission to change how doctors ...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) ...
Amneal has received the Food and Drug Administration’s approval of risperidone extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, which is the generic of ...